You can buy or sell SAVA and other stocks, options, ETFs, and crypto commission-free!
Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer's disease, including PTI-125 and PTI-125Dx. Read More The company was founded by Remi Barbier and Barry M. Sherman in May 1998 and is headquartered in Austin, TX.
52 Week High
52 Week Low
— per share
Expected Aug 10, Pre-Market